Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG:2315)
Hong Kong
· Delayed Price · Currency is HKD
59.50
+5.55 (10.29%)
At close: Mar 10, 2026
HKG:2315 Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 35,280 | 23,585 | 3,395 | 4,785 | 10,245 | - | |
| Market Cap Growth | 982.52% | 594.71% | -29.05% | -53.29% | - | - | |
| Enterprise Value | 35,424 | 23,729 | 3,562 | 4,682 | 10,003 | - | |
| Last Close Price | 53.95 | 35.30 | 8.50 | 11.98 | 25.65 | - | |
| PE Ratio | 112.75 | 122.37 | 95.11 | - | - | - | |
| PS Ratio | 22.99 | 15.37 | 3.25 | 6.06 | 16.97 | - | |
| PB Ratio | - | - | 3.80 | 5.50 | 7.87 | - | |
| P/TBV Ratio | - | - | 3.92 | 5.73 | 8.12 | - | |
| P/FCF Ratio | - | - | 18.32 | - | - | - | |
| P/OCF Ratio | - | - | 15.10 | - | - | - | |
| EV/Sales Ratio | 23.09 | 15.47 | 3.41 | 5.93 | 16.57 | - | |
| EV/EBITDA Ratio | 97.21 | 65.12 | 11.58 | - | - | - | |
| EV/EBIT Ratio | 168.80 | 113.08 | 22.29 | - | - | - | |
| EV/FCF Ratio | - | - | 19.23 | - | - | - | |
| Debt / Equity Ratio | - | - | 0.68 | 0.69 | 0.36 | 0.07 | |
| Debt / EBITDA Ratio | - | - | 1.80 | - | - | - | |
| Debt / FCF Ratio | - | - | 3.28 | - | - | - | |
| Net Debt / Equity Ratio | - | - | 0.19 | 0.14 | -0.20 | -0.39 | |
| Net Debt / EBITDA Ratio | - | - | 0.55 | -0.71 | 0.49 | 1.16 | |
| Net Debt / FCF Ratio | - | - | 0.91 | -0.54 | 0.42 | 0.86 | |
| Asset Turnover | - | - | 0.40 | 0.27 | 0.21 | 0.15 | |
| Inventory Turnover | - | - | 26.80 | 12.25 | 6.09 | 6.11 | |
| Quick Ratio | - | - | 1.22 | 1.01 | 1.25 | 1.55 | |
| Current Ratio | - | - | 1.53 | 1.25 | 1.52 | 1.96 | |
| Return on Equity (ROE) | - | - | 4.12% | -39.45% | -50.12% | -40.27% | |
| Return on Assets (ROA) | - | - | 3.86% | -6.94% | -14.81% | -14.02% | |
| Return on Invested Capital (ROIC) | 33.93% | 34.82% | 12.36% | -31.99% | -71.53% | -76.89% | |
| Return on Capital Employed (ROCE) | - | - | 8.00% | -15.60% | -27.60% | -28.00% | |
| Earnings Yield | 0.55% | 0.82% | 1.05% | -8.82% | -6.64% | - | |
| FCF Yield | - | - | 5.46% | -4.68% | -6.00% | - | |
| Buyback Yield / Dilution | -1.20% | -1.20% | 0.08% | -4.54% | -5.13% | -180.82% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.